Evidence map›Paper›PMID 38114609›Full record

ReviewPediatric research2024

Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series).

Eleanor J Molloy, Mohamed El-Dib, Janet Soul, Sandra Juul, Alistair J Gunn, Manon Bender, Fernando Gonzalez, Cynthia Bearer, Yvonne Wu, Nicola J Robertson and 12 more

Open access · hybridAbstract readReview
In one paragraph

Review in Pediatric research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
25.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Neurodevelopmental forecasting in preterms: aEEG at 32 weeks vs. MRI at term in predicting 2-year outcomes.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Perinatal Neuroprotection in Preterm Birth.Geburtshilfe und Frauenheilkunde · 2025
    Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 20 institutions in 6 countries.

Eleanor J MolloyPaediatrics, Trinity College Dublin, Trinity Research in Childhood Centre (TRICC), Dublin, Ireland. Eleanor.molloy@tcd.ie.
Mohamed El-DibDepartment of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Janet SoulDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Sandra JuulDepartment of Pediatrics, University of Washington, Seattle, WA, USA.
Alistair J GunnDepartments of Physiology and Paediatrics, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Manon BenderDepartment of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Fernando GonzalezDepartment of Neurology, Division of Child Neurology, University of California, San Francisco, California, USA.
Cynthia BearerDivision of Neonatology, Department of Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, Ohio, USA.
Yvonne WuDepartment of Neurology, University of California San Francisco, San Francisco, California, USA.
Nicola J RobertsonInstitute for Women's Health, University College London, London, UK.
Mike CottonDepartment of Pediatrics, Duke University, Durham, North Carolina, USA.
Aoife BranaganPaediatrics, Trinity College Dublin, Trinity Research in Childhood Centre (TRICC), Dublin, Ireland.
Tim HurleyPaediatrics, Trinity College Dublin, Trinity Research in Childhood Centre (TRICC), Dublin, Ireland.
Sidhartha TanWayne State University School of Medicine, Detroit, Michigan, USA.
Abbot LaptookDepartment of Pediatrics, Women and Infants Hospital, Brown University, Providence, Rhode Island, USA.
Topun AustinDepartment of Paediatrics, University of Cambridge, Cambridge, UK.
Khorshid MohammadSection of Neonatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
Elizabeth RogersDepartment of Pediatrics, University of California, San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Karen LuytTranslational Health Sciences, University of Bristol, Bristol, UK.
Pia WintermarkDivision of Neonatology, Montreal Children's Hospital, Montreal, Quebec, Canada.
Sonia Lomeli BonifacioDivision of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Newborn Brain Society Guidelines and Publications Committee
University of California, San Francisco · USDuke University · USHarvard University · USHospital for Sick Children · CAMcGill University Health Centre · CAStanford University · USUniversity of Edinburgh · GBBrown University · USCase Western Reserve University · USCleveland Clinic · USCoombe Women & Infants University Hospital · IELurie Children's Hospital · USTrinity College · CATrinity College Dublin · IEUCSF Benioff Children's Hospital · USUniversity Hospitals Bristol and Weston NHS Foundation TrustUniversity of Auckland · NZUniversity of Calgary · CAUniversity of Cambridge · GBUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The survival of preterm infants has steadily improved thanks to advances in perinatal and neonatal intensive clinical care. The focus is now on finding ways to improve morbidities, especially neurological outcomes. Although antenatal steroids and magnesium for preterm infants have become routine therapies, studies have mainly demonstrated short-term benefits for antenatal steroid therapy but limited evidence for impact on long-term neurodevelopmental outcomes. Further advances in neuroprotective and neurorestorative therapies, improved neuromonitoring modalities to optimize recruitment in trials, and improved biomarkers to assess the response to treatment are essential. Among the most promising agents, multipotential stem cells, immunomodulation, and anti-inflammatory therapies can improve neural outcomes in preclinical studies and are the subject of considerable ongoing research. In the meantime, bundles of care protecting and nurturing the brain in the neonatal intensive care unit and beyond should be widely implemented in an effort to limit injury and promote neuroplasticity. IMPACT: With improved survival of preterm infants due to improved antenatal and neonatal care, our focus must now be to improve long-term neurological and neurodevelopmental outcomes. This review details the multifactorial pathogenesis of preterm brain injury and neuroprotective strategies in use at present, including antenatal care, seizure management and non-pharmacological NICU care. We discuss treatment strategies that are being evaluated as potential interventions to improve the neurodevelopmental outcomes of infants born prematurely.

Indexed as

Brain InjuriesInfant, PrematureIntensive Care Units, NeonatalNeuroprotective AgentsHumansInfant, NewbornNeuroprotectionNeuroprotective Agents

Identifiers

PMID38114609
PMCPMC11035150
OpenAlexW4389943395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.